Article
Drug Repurposing And Second Medical Use Patents: Unlocking New Value From Known Medicines
Pharmaceutical companies are increasingly turning to drug repurposing to accelerate development timelines and reduce risk, identifying new therapeutic applications for known compounds. This strategy offers significant clinical and commercial advantages, from faster patient access to extended product lifecycles, but raises complex questions about intellectual property protection and regulatory exclusivity. The article examines how second medical use patents and strategic IP planning enable innovators to secu

Potter Clarkson LLP








